COMP <GO>
IREN vs BAC // EV/EBITDA & P/E VALUATION
IREN Limited (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: IREN 7
— BAC 7
▲ EV/EBITDA & P/E VALUATION LEADER: IREN
LAST: $23.95 (-8.76%) • MKT CAP: $10.62B
valuation
18.3x
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
valuation
30.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IREN VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IREN | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | 41.00% | +27.30 | IREN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 2.50% | -1.30 | BAC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.3x | 30.2x | -11.90 | IREN | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | 2.10% | -5.18 | BAC | /fcf-yield <GO> |
| Operating Margin | 3.50% | 32.90% | -29.40 | BAC | /operating-margins <GO> |
| Net Profit Margin | 17.40% | 27.00% | -9.60 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 167.70% | 6.80% | +160.90 | IREN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 0.45 | +1.43 | IREN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | IREN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.60% | +0.60 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.2 | 27.7 | +2.52 | IREN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.90 | +0.18 | IREN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 102.6x | 10.9x | +91.70 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.62B | $357.61B | -$346.99B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IREN REV | BAC REV | IREN GROSS % | BAC GROSS % | IREN FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.0M | $113.10B | 68.3% | 44.0% | -$327.6M | $7.52B |
| FY 2024 | $187.2M | $105.86B | 53.5% | 44.0% | -$89.6M | -$13.57B |
| FY 2023 | $75.5M | $102.77B | 44.0% | 44.0% | $2.3M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IREN // BETA 1.08
BAC // BETA 0.90